Post-approval studies (Phase 4)WithdrawnNCT02760615What this trial is testingPhase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction StudyWho this might be right forColitis, UlcerativeCrohn Disease Takeda
Large-scale testing (Phase 3)Ended earlyNCT03467958What this trial is testingAn Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn Disease Celgene 854
Large-scale testing (Phase 3)Study completedNCT03945019What this trial is testingCT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)Who this might be right forCrohn's Disease Celltrion 396
Not applicableStudy completedNCT05815355What this trial is testingEfficacy of Exclusive Enteral Nutrition in Adult Active Crohn's DiseaseWho this might be right forCrohn's Disease Sixth Affiliated Hospital, Sun Yat-sen University 48
Not applicableEnded earlyNCT00936585What this trial is testingNIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's DiseaseWho this might be right forColitisCrohn's DiseaseInflammatory Bowel Disease National Institutes of Health Clinical Center (CC) 2
Large-scale testing (Phase 3)Study completedNCT01514240What this trial is testingPhase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in JapanWho this might be right forCrohn's Disease AstraZeneca 123
Early research (Phase 1)WithdrawnNCT02249078What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 3 Subcutaneous and 1 Intravenous Dose of E6011 in Subjects With Active Crohn's DiseaseWho this might be right forCrohn's Disease Eisai Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06233461What this trial is testingA Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Takeda 268
Large-scale testing (Phase 3)Study completedNCT00321412What this trial is testingSafety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With FistulasWho this might be right forInflammatory Bowel DiseaseIntestinal Fistula Ocera Therapeutics 191
Not applicableLooking for participantsNCT05733845What this trial is testingEvaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel DiseaseWho this might be right forCrohn's DiseaseUlcerative Colitis Central Hospital, Nancy, France 100
Testing effectiveness (Phase 2)Looking for participantsNCT07078994What this trial is testingClinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's DiseaseWho this might be right forCrohn's Disease (CD) Biocad 204
Early research (Phase 1)Study completedNCT04254783What this trial is testingEvaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's DiseaseWho this might be right forUlcerative Colitis (UC)Crohn's Disease AbbVie 20
Testing effectiveness (Phase 2)Study completedNCT02389790What this trial is testingExtension Study of MT-1303 in Subjects With Crohn's DiseaseWho this might be right forCrohn's Disease Tanabe Pharma Corporation 46
Not applicableStudy completedNCT03173144What this trial is testingChronic Inflammatory Disease, Lifestyle and Treatment ResponseWho this might be right forAutoimmune DiseasesInflammatory Bowel DiseasesCrohn Disease (CD)+7 more University of Southern Denmark 233
Testing effectiveness (Phase 2)Ended earlyNCT00206661What this trial is testingSafety and Efficacy Study in the Treatment of Pediatric Crohn's DiseaseWho this might be right forCrohn Disease Genzyme, a Sanofi Company 22
Testing effectiveness (Phase 2)Ended earlyNCT00152841What this trial is testingEffect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative ColitisWho this might be right forCrohn's DiseaseUlcerative ColitisMild or Moderate Anaemia University Health Network, Toronto 30
Post-approval studies (Phase 4)WithdrawnNCT04530877What this trial is testingExclusive Enteral Nutrition vs. Infliximab in Chinese CD PatientsWho this might be right forCrohn's DiseaseExclusive Enteral NutritionInfliximab+1 more Children's Hospital of Fudan University
Not applicableStudy completedNCT06459297What this trial is testingStudy of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's DiseaseWho this might be right forUlcerative ColitisCrohn's Disease AbbVie 105
Large-scale testing (Phase 3)Ended earlyNCT04173273What this trial is testingA Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Pfizer 379
Not applicableUnknownNCT03088449What this trial is testingPersonalising Anti-TNF Therapy in Crohns Disease (PANTS)Who this might be right forCrohn Disease Royal Devon and Exeter NHS Foundation Trust 1,750